「to」の検索結果
425件：356～360件目を表示
-
Sales Trends and Breakdown | About Senju | SENJU Pharmaceutical
Company Profile Milestones in Our History
https://www.senju.co.jp/english/about/sales.html -
お知らせ | 千寿製薬株式会社
or Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has develo...
http://www.senju.co.jp/english/news/ -
Publications | Research & Development | SENJU Pharmaceutica
cebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, J...
http://www.senju.co.jp/english/rd/thesis/ -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
e East UAE Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmaceticals Factory BRONUCK Iraq Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmacetic...
http://www.senju.co.jp/english/global/world.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
ore Overseas ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cel...
http://www.senju.co.jp/english/rd/society/